Elevance Health (ELV) vs Natera (NTRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Natera (NTRA) has outperformed Elevance Health (ELV) over the past year, gaining 134.7% versus a gain of 13.1%. Over five years, NTRA leads with a +257.1% price change compared with +2.9% for ELV. Elevance Health is the larger company by market cap ($86.47 billion vs $56.01 billion), about 1.5 times the size, while Natera is growing revenue faster (+35.9% vs +12.5%).
Elevance Health pays a dividend yielding 1.72%, while Natera does not currently pay one. Elevance Health converts more of its revenue into profit, with a net margin of 2.8% versus -9.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELV | NTRA |
|---|---|---|
| Share price | $398.71 | $388.54 |
| Market cap | $86.47B | $56.01B |
| 1-day change | -1.39% | -1.77% |
| YTD return | +15.34% | +72.67% |
| 1-year return | +13.10% | +134.71% |
| 5-year return | +2.86% | +257.10% |
| P/E ratio (TTM) | 17.65 | — |
| Forward P/E | 13.50 | — |
| EPS (TTM) | $22.59 | $-1.35 |
| Dividend yield | 1.72% | 0.00% |
| Annual dividend | $6.86 | $0.00 |
| Revenue (latest FY) | $199.13B | $2.31B |
| Revenue growth (YoY) | +12.49% | +35.90% |
| Net income (latest FY) | $5.66B | $-208.16M |
| Gross margin | 89.36% | — |
| Operating margin | 3.62% | -13.44% |
| Net margin | 2.84% | -9.03% |
| 52-week high | $436.24 | $437.41 |
| 52-week low | $274.84 | $167.99 |
| Distance from 52-week high | -8.60% | -11.17% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +13.24% | -2.86% |
| Average volume | 1.19M | 1.44M |
| Shares outstanding | 216.87M | 144.14M |
| Employees | 96,129 | 6,135 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NTRA has outperformed ELV by 121.6 percentage points over the past year.
- Elevance Health offers a meaningfully higher dividend yield (1.72% vs 0.00%).
- Elevance Health is more profitable, keeping 2.8 cents of every revenue dollar as net income versus -9.0 cents for Natera.
- Natera grew revenue faster in its latest fiscal year (+35.90% vs +12.49%).
About Elevance Health
ELV stock →Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Health Care · Medical Specialities · 96,129 employees
About Natera
NTRA stock →Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.
Health Care · Medical Specialities · 6,135 employees
ELV vs NTRA FAQ
Which is bigger, Elevance Health or Natera?
Elevance Health (ELV) is larger, with a market capitalization of $86.47B compared with $56.01B for Natera (NTRA).
Which stock has performed better over the past year, ELV or NTRA?
NTRA returned +134.71% over the past 12 months, compared with +13.10% for ELV (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Elevance Health or Natera?
Elevance Health pays a dividend yielding 1.72%, while Natera does not currently pay a regular dividend.
Are Elevance Health and Natera in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.